series-b
Stage
1
Investors
About
Alantos Pharmaceuticals is a chemistry-driven drug discovery company focused on developing small molecule therapeutics that inhibit proteases involved in inflammation and metabolic diseases, including type II diabetes and osteoarthritis.
Explore Alantos Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.